PAX1 and cervical carcinoma: Women with hypermethylation of PAX1 had a significantly higher incidence of CIN3, especially cervical cancer, compared with CIN2 and below, but there was no significant difference between CIN1 and CIN2, indicating its potential role in the late status of cervical lesions.